ArticleiGIE : innovation, investigation and insights2024
Effect of prophylactic biliary stent in reducing recurrence of adverse events among patients awaiting cholecystectomy: an analysis of the Nationwide Readmissions Database.
Article in iGIE : innovation, investigation and insights, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prophylactic Biliary Stenting After Stone Clearance Improves the Safety of Needle-Knife Fistulotomy: A Propensity Score-Matched Analysis.JGH open : an open access journal of gastroenterology and hepatology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: In patients awaiting cholecystectomy, the role of endoscopic biliary sphincterotomy (EST) with biliary stenting is controversial. We aimed to assess the impact of biliary stenting in these patients. Methods: The Nationwide Readmissions Database (2016-2020) was queried to identify adult hospitalizations with cholelithiasis and choledocholithiasis that underwent ERCP with EST without biliary stenting (group 1) and biliary stenting (group 2). Readmission characteristics, post-ERCP pancreatitis (PEP), mean length of hospital stay (LOS), and mean total hospitalization charge (THC) were analyzed. Results: For all biliary events, the risks of 30-day (1.18% vs .67%; adjusted hazard ratio [aHR], 1.78, 95% confidence interval [CI], 1.55-2.04; Conclusions: For biliary events, patients with biliary stenting had higher readmission risk, LOS, THC, and PEP within 48 hours after discharge compared with nonstented patients.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.